Eledon Pharmaceuticals Inc

ELDN
2,34
-0,10 (-4,10%)
10 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202413:30GLOBEEledon Pharmaceuticals Reports First Quarter 2024 Operating..
09/5/202413:00GLOBEEledon Pharmaceuticals to Present Updated Data from Ongoing..
07/5/202413:15EDGAR2Form 8-K - Current report
07/5/202413:05GLOBEEledon Announces Clinical Progress with Tegoprubart in the..
07/5/202413:00GLOBEEledon Pharmaceuticals Announces Oversubscribed $50 Million..
28/3/202421:01GLOBEEledon Pharmaceuticals Reports Fourth Quarter and Full Year..
25/3/202421:56GLOBEEledon Pharmaceuticals Announces 12th Participant Enrolled..
21/3/202415:31GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart in..
14/2/202421:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202421:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:01GLOBEEledon Reports Inducement Grants Under Nasdaq Listing Rule..
04/1/202422:40GLOBEEledon Pharmaceuticals Highlights Recent Business Milestones..
05/12/202300:00GLOBEEledon Reports Inducement Grants Under Nasdaq Listing Rule..
29/11/202322:05GLOBEEledon Pharmaceuticals to Present at Noble Capital Markets'..
09/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:01GLOBEEledon Pharmaceuticals Reports Third Quarter 2023 Operating..
08/11/202322:05GLOBEEledon Pharmaceuticals to Present at Jefferies London..
02/11/202321:30EDGAR2Form 8-K - Current report
02/11/202314:05GLOBEEledon Reports Updated Data from Ongoing Phase 1b Trial..
23/10/202313:00GLOBEEledon Pharmaceuticals Strengthens Leadership Team with..
13/10/202313:00GLOBEEledon Pharmaceuticals to Present Data from Ongoing Phase 1b..
03/10/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202323:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202323:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202313:30EDGAR2Form 8-K - Current report
02/10/202313:00GLOBEEledon Pharmaceuticals Appoints Kidney Transplant Specialist..
25/9/202313:00GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart..
20/9/202322:05GLOBEEledon Pharmaceuticals to Participate at the 2023 Cantor..
13/9/202322:42EDGAR2Form 8-K - Current report
11/9/202313:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
06/9/202313:00GLOBEEledon Pharmaceuticals Announces Publication of Data Showing..
05/9/202313:00GLOBEEledon Pharmaceuticals Announces First Participant Dosed in..
16/8/202313:00GLOBEEledon Pharmaceuticals Announces Dosing of 10th Patient in..
10/8/202323:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:05EDGAR2Form 8-K - Current report
10/8/202313:00GLOBEEledon Pharmaceuticals Reports Second Quarter 2023 Operating..
02/6/202314:00GLOBEEledon Pharmaceuticals to Present at Jefferies Healthcare..
11/5/202322:01GLOBEEledon Pharmaceuticals Reports First Quarter 2023 Operating..
Apertura: 2,43 Min: 2,27 Max: 2,49
Chiusura: 2,44

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network